Replies to post #50837 on Biotech Values

[go seek]

re: VRUS

appears there is are high expectations for Clevudine...

wondering what would be the earliest it could move to market - 2009?

although it made it through to registration in Korea...
what does it face in P3 trials, that it did not face in S. Korea?

possible SVR for HBV? hmm...